万古霉素在腹膜透析中的应用：治疗中的临床药理学考虑。
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.
机构信息
Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA.
Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA.
出版信息
Perit Dial Int. 2020 Jul;40(4):384-393. doi: 10.1177/0896860819889774. Epub 2020 Feb 17.
Abstract
Intraperitoneal vancomycin is the first-line therapy in the management of peritoneal dialysis (PD)-related peritonitis. However, due to the paucity of data, vancomycin dosing for peritonitis in patients on automated peritoneal dialysis (APD) is empiric and based on clinical experience rather than evidence. Studies in continuous ambulatory peritoneal dialysis (CAPD) patients have been used to provide guidelines for dosing and are often extrapolated for APD use, but it is unclear whether this is appropriate. This review summarizes the available pharmacokinetic data used to inform optimal dosing in patients on CAPD or APD. The determinants of vancomycin disposition and pharmacodynamic effects are critically summarized, knowledge gaps explored, and a vancomycin dosing algorithm in PD patients is proposed.
摘要
腹腔内万古霉素是腹膜透析（PD）相关腹膜炎治疗的一线药物。然而，由于数据有限，自动化腹膜透析（APD）患者的腹膜炎万古霉素剂量是经验性的，基于临床经验而不是证据。在持续非卧床腹膜透析（CAPD）患者中的研究已被用于提供剂量指南，并经常被外推用于 APD，但尚不清楚这是否合适。本综述总结了用于指导 CAPD 或 APD 患者最佳剂量的可用药代动力学数据。本文还批判性地总结了影响万古霉素处置和药效学的因素，探讨了知识空白，并提出了 PD 患者的万古霉素剂量算法。
相似文献
1
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.万古霉素在腹膜透析中的应用：治疗中的临床药理学考虑。
Perit Dial Int. 2020 Jul;40(4):384-393. doi: 10.1177/0896860819889774. Epub 2020 Feb 17.
2
Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.接受腹膜透析的儿童腹腔内给药后万古霉素的处置情况。
Perit Dial Int. 2007 Jan-Feb;27(1):79-85.
3
Treatment of peritonitis in APD: pharmacokinetic principles.腹膜透析相关性腹膜炎的治疗：药代动力学原理
Semin Dial. 2002 Nov-Dec;15(6):418-21. doi: 10.1046/j.1525-139x.2002.00103.x.
4
Peritonitis and antibiotic therapy in patients on cycler peritoneal dialysis--an update.循环式腹膜透析患者的腹膜炎与抗生素治疗——最新进展
Adv Perit Dial. 2000;16:229-32.
5
Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.英国单中心关于腹膜透析相关性腹膜炎治疗的经验——抗生素水平与治疗结果
Nephrol Dial Transplant. 2007 Jun;22(6):1714-9. doi: 10.1093/ndt/gfm079. Epub 2007 Mar 17.
6
Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.万古霉素在腹膜炎患者持续性不卧床腹膜透析中的药代动力学。
Eur J Pharm Sci. 2011 Jul 17;43(4):212-6. doi: 10.1016/j.ejps.2011.04.006. Epub 2011 Apr 20.
7
Review of Antibiotic Dosing with Peritonitis in APD.APD 中腹膜炎的抗生素剂量调整综述。
Perit Dial Int. 2019 Jul-Aug;39(4):299-305. doi: 10.3747/pdi.2018.00209.
8
Automated peritoneal dialysis: new implications for pharmacists.自动化腹膜透析：对药剂师的新启示。
Ann Pharmacother. 1997 Jun;31(6):756-64. doi: 10.1177/106002809703100616.
9
Practice variations in antibiotic administration for the management of peritonitis in patients on automated peritoneal dialysis in Australia and New Zealand.在澳大利亚和新西兰，接受自动化腹膜透析治疗的腹膜炎患者的抗生素管理中，抗生素给药实践存在差异。
Perit Dial Int. 2022 Nov;42(6):647-651. doi: 10.1177/08968608211069231. Epub 2022 Jan 12.
10
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.在墨西哥一家腹膜透析中心，与持续性非卧床腹膜透析相比，接受自动化腹膜透析治疗的患者其患者/技术生存率及腹膜炎发生率得到改善。
Kidney Int Suppl. 2008 Apr(108):S76-80. doi: 10.1038/sj.ki.5002606.
引用本文的文献
1
Intraperitoneally Administered Vancomycin Results in Suboptimal Serum and Peritoneal Effluent Drug Levels in Patients with PD-related Peritonitis.对于患有与腹膜透析相关腹膜炎的患者，腹腔内注射万古霉素会导致血清和腹腔积液中的药物水平未达最佳。
Indian J Nephrol. 2025 Jul-Aug;35(4):524-529. doi: 10.25259/IJN_59_2024. Epub 2024 Sep 19.
2
Simplifying Antibiotic Management of Peritonitis in APD: Evidence from a Non-Inferiority Randomized Trial.简化持续性非卧床腹膜透析相关性腹膜炎的抗生素管理：一项非劣效性随机试验的证据
Antibiotics (Basel). 2025 Jul 24;14(8):747. doi: 10.3390/antibiotics14080747.
3
Unveiling the drivers of vancomycin-resistant enterococcus in China: A comprehensive ecological study.揭示中国耐万古霉素肠球菌的驱动因素：一项全面的生态学研究。
Infect Med (Beijing). 2024 Dec 21;4(1):100159. doi: 10.1016/j.imj.2024.100159. eCollection 2025 Mar.
4
Linking clinical manifestations and causative organisms may provide clues for the treatment of peritoneal dialysis-associated peritonitis.将临床表现与病原体联系起来可能为腹膜透析相关性腹膜炎的治疗提供线索。
BMC Nephrol. 2024 Sep 27;25(1):322. doi: 10.1186/s12882-024-03756-y.
5
Hemodialysis treatment of vancomycin-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome in a patient undergoing peritoneal dialysis.患者行腹膜透析时发生万古霉素引起的药物反应伴嗜酸性粒细胞增多和全身症状/药物超敏综合征，给予血液透析治疗。
CEN Case Rep. 2024 Oct;13(5):339-345. doi: 10.1007/s13730-023-00847-x. Epub 2024 Feb 10.
6
The Association Between Serum Vancomycin Level and Clinical Outcome in Patients With Peritoneal Dialysis Associated Peritonitis.腹膜透析相关性腹膜炎患者血清万古霉素水平与临床结局的关联
Kidney Int Rep. 2023 Sep 17;8(12):2646-2653. doi: 10.1016/j.ekir.2023.09.013. eCollection 2023 Dec.
7
Antimicrobial-loaded biodegradable nanoemulsions for efficient clearance of intracellular pathogens in bacterial peritonitis.载抗菌剂的可生物降解纳米乳剂用于有效清除细菌性腹膜炎中的细胞内病原体。
Biomaterials. 2023 Nov;302:122344. doi: 10.1016/j.biomaterials.2023.122344. Epub 2023 Oct 10.
8
First Case Report of Peritoneal Dialysis-associated Peritonitis Caused by Lysinibacillus sphaericus.首例由球形芽胞杆菌引起的腹膜透析相关性腹膜炎的病例报告。
Intern Med. 2023 Oct 1;62(19):2919-2922. doi: 10.2169/internalmedicine.1141-22. Epub 2023 Feb 22.
9
The Correlation between Serum Sclerostin Level and Arterial Stiffness in Peritoneal Dialysis Patients.腹膜透析患者血清硬化素水平与动脉僵硬度的相关性
Evid Based Complement Alternat Med. 2022 Aug 10;2022:4247782. doi: 10.1155/2022/4247782. eCollection 2022.
10
Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis.患者在接受自动化腹膜透析时的万古霉素腹腔内药代动力学。
Clin Transl Sci. 2022 Mar;15(3):649-657. doi: 10.1111/cts.13182. Epub 2021 Nov 9.
本文引用的文献
1
Vancomycin Removal During High-Volume Peritoneal Dialysis in Acute Kidney Injury Patients.高容量腹膜透析治疗急性肾损伤患者时的万古霉素清除。
Perit Dial Int. 2019 Mar-Apr;39(2):183-187. doi: 10.3747/pdi.2018.00092.
2
Peritoneal dialysis-related peritonitis: challenges and solutions.腹膜透析相关性腹膜炎：挑战与解决方案
Int J Nephrol Renovasc Dis. 2018 Jun 11;11:173-186. doi: 10.2147/IJNRD.S123618. eCollection 2018.
3
Residual Kidney Function and Peritoneal Dialysis-Associated Peritonitis Treatment Outcomes.残余肾功能与腹膜透析相关性腹膜炎治疗结局。
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2016-2022. doi: 10.2215/CJN.00630117. Epub 2017 Nov 7.
4
The Nephrotoxicity of Vancomycin.万古霉素的肾毒性。
Clin Pharmacol Ther. 2017 Sep;102(3):459-469. doi: 10.1002/cpt.726. Epub 2017 Jun 5.
5
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.国际腹膜透析学会腹膜炎推荐意见：2016年预防与治疗更新版
Perit Dial Int. 2016 Sep 10;36(5):481-508. doi: 10.3747/pdi.2016.00078. Epub 2016 Jun 9.
6
Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.应用于儿科人群自动腹膜透析的腹膜透析液中抗生素的稳定性和相容性
Perit Dial Int. 2016;36(6):676-679. doi: 10.3747/pdi.2015.00018. Epub 2016 May 4.
7
An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.一项关于美罗培南在接受自动化腹膜透析患者中腹腔内和静脉内给药后的开放、随机、单中心、交叉药代动力学研究。
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2790-7. doi: 10.1128/AAC.02664-15. Print 2016 May.
8
Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).腹透液外7.5%艾考糊精腹膜透析袋中腹腔内注射用抗生素的稳定性（STAB研究）
Perit Dial Int. 2016 Jul-Aug;36(4):421-6. doi: 10.3747/pdi.2015.00062. Epub 2015 Oct 22.
9
Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis.对接受自动腹膜透析的患者常用静脉注射万古霉素给药方案的药效学特征进行评估。
J Antimicrob Chemother. 2014 Jul;69(7):1873-6. doi: 10.1093/jac/dku081. Epub 2014 Apr 10.
10
Vancomycin: the tale of the vanquisher and the pyrrhic victory.万古霉素：征服者的故事与惨胜
Perit Dial Int. 2014 Mar-Apr;34(2):154-61. doi: 10.3747/pdi.2014.00001.
Zotero 插件